| Pharmaceutical Information |
| Drug Name |
Zinc |
| Drug ID |
BADD_D02385 |
| Description |
A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with anemia, short stature, hypogonadism, impaired wound healing, and geophagia. It is identified by the symbol _Zn_ [L2098].
A newer study suggests implies that an imbalance of zinc is associated with the neuronal damage associated with traumatic brain injury, stroke, and seizures [A32465].
Understanding the mechanisms that control brain zinc homeostasis is, therefore, imperative to the development of preventive and treatment regimens for these and other neurological disorders [A32465].
In addition to the above, recent review articles have already demonstrated the important role of zinc in the pathophysiology and treatment of affective disorders, plus discussed the potential value of zinc as a marker of these diseases [L2097]. Most recently, research has shown that polymorphism of the common polymorphism in zinc transporter _SLC30A8/ZnT8_ may increase susceptibility to type 2 diabetes provided novel insights into the role of zinc in diabetes [A32416]. |
| Indications and Usage |
Zinc can be used for the treatment and prevention of zinc deficiency/its consequences, including stunted growth and acute diarrhea in children, and slowed wound healing. It is also utilized for boosting the immune system, treating the common cold and recurrent ear infections, as well as preventing lower respiratory tract infections [L2172].
|
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB01593
|
| KEGG ID |
Not Available
|
| MeSH ID |
D015032
|
| PubChem ID |
23994
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
0220-5433; 64117-052; 0220-5465; 68428-712; 0220-5438; 0220-5437; 62106-5367 |
| UNII |
J41CSQ7QDS
|
| Synonyms |
Zinc |
|
| Chemical Information |
| Molecular Formula |
Zn |
| CAS Registry Number |
7440-66-6 |
| SMILES |
[Zn] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Pancreatitis | 07.18.01.001 | - | - | | | Epigastric discomfort | 07.01.02.004 | - | - | Not Available |
|
The 1th Page
1
Total 1 Pages
|
|
